Cargando…

CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy

We identify factors associated with the normalization of the CD4+:CD8+ T cell ratio among UK Collaborative HIV Cohort study participants, and describe the association of the CD4+ and CD8+ T cell counts and the CD4+:CD8+ T cell ratio, with the risk of new AIDS events among individuals who achieve a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okhai, Hajra, Vivancos-Gallego, María Jesús, Hill, Teresa, Sabin, Caroline A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549010/ https://www.ncbi.nlm.nih.gov/pubmed/32664736 http://dx.doi.org/10.1089/aid.2020.0106

Ejemplares similares

Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom
por: van Halsema, Clare L., et al.
Publicado: (2020)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
por: Serrano-Villar, Sergio, et al.
Publicado: (2014)

Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
por: Han, Win Min, et al.
Publicado: (2018)

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
por: Martínez-Sanz, Javier, et al.
Publicado: (2023)

Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy
por: Leung, Victor, et al.
Publicado: (2013)

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
por: Thornhill, John, et al.
Publicado: (2016)

Associations of menopausal age with virological outcomes and engagement in care among women living with HIV in the UK
por: Okhai, Hajra, et al.
Publicado: (2020)

When should antiretroviral therapy be started in HIV-positive persons?
por: Sabin, Caroline A
Publicado: (2010)

Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study
por: De Salvador-Guillouët, F., et al.
Publicado: (2015)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
por: Chammartin, Frédérique, et al.
Publicado: (2022)

The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment
por: Bernal, Enrique, et al.
Publicado: (2014)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study
por: Hema, Mariam Noelie, et al.
Publicado: (2016)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

The predictive role of CD4(+) cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China
por: Li, Chong-Xi, et al.
Publicado: (2019)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
por: Serrano-Villar, Sergio, et al.
Publicado: (2014)

CD3(+)T, CD4(+)T, CD8(+)T, and CD4(+)T/CD8(+)T Ratio and Quantity of γδT Cells in Peripheral Blood of HIV-Infected/AIDS Patients and Its Clinical Significance
por: Zhao, Nange, et al.
Publicado: (2021)

Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study
por: Lee, Shui Shan, et al.
Publicado: (2017)

Retracted: CD3(+)T, CD4(+)T, CD8(+)T, and CD4(+)T/CD8(+)T Ratio and Quantity of γδT Cells in Peripheral Blood of HIV-Infected/AIDS Patients and Its Clinical Significance
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Identification of CD8(+) T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy
por: Perdomo-Celis, Federico, et al.
Publicado: (2022)

Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?
por: Sabin, Caroline A
Publicado: (2013)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

Short- and long-term effects of antiretroviral therapy on peripheral regulatory CD4(+)/CD25(hi)/CD127(low) T lymphocytes in people living with HIV/AIDS
por: Hu, Ronghua, et al.
Publicado: (2022)

The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2019)

Establishment of Normal Reference Intervals for CD3(+), CD4(+), CD8(+), and CD4(+) to CD8(+) Ratio of T Lymphocytes in HIV Negative Adults from University of Gondar Hospital, North West Ethiopia
por: Gize, Addisu, et al.
Publicado: (2014)

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
por: Gras, Luuk, et al.
Publicado: (2019)

Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies
por: Wolbers, Marcel, et al.
Publicado: (2010)

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs
Publicado: (2018)

Predicting AIDS-related events using CD4 percentage or CD4 absolute counts
por: Pirzada, Yasmin, et al.
Publicado: (2006)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade
por: Wolday, Dawit, et al.
Publicado: (2020)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance
por: Han, Jingqi, et al.
Publicado: (2022)

CD4/CD8 Ratio as a Predictor for the Occurrence of Metabolic Syndrome in HIV / AIDS Patients During 6 Months of cART Therapy
por: Gojak, Refet, et al.
Publicado: (2019)

Correlation of CD4/CD8 Ratio with Carotid Intima-Media Layer Thickness in HIV/AIDS Patients at Sanglah General Hospital, Bali, Indonesia
por: Utama, Susila, et al.
Publicado: (2019)

Harnessing CD8(+) T Cells Under HIV Antiretroviral Therapy
por: Warren, Joanna A., et al.
Publicado: (2019)

Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials
por: Schechter, Mauro
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dbjrbfnefklch9hccv6a07trer